M. Feely - Concepedia

Author

M. Feely

Leeds General Infirmary

Also Known As

>Morgan Feely, M Feely, M P Feely, M. Feely, M. P. FEELY, M. P. Feely, M.P. Feely, MP Feely, Mason G. Feely

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Leeds General Infirmary University of Leeds St James's University Hospital

About

M. Feely is an author at Leeds General Infirmary specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	669
2	Social Sciences	4	4	170
3	Public Health	3	3	85
4	Nursing	1	1	25
5	Emergency Medicine	1	1	98

M. Feely

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily T Pullar, A. J. Birtwell, Philip Wiles, Clinical Pharmacology & Therapeutics	1988	169
The pharmacokinetics of methadone in healthy subjects and opiate users Kim Wolff, Amin Rostami‐Hodjegan, Susan Shires, British Journal of Clinical Pharmacology	1997	105
Poor Compliance Is a Major Factor in Unstable Outpatient Control of Anticoagulant Therapy Jeremy R.M. Haigh, Lesley E. Rhodes, S Peaker, Thrombosis and Haemostasis PharmacotherapyThrombosisVenous ThrombosisPrescribed WarfarinPoor Compliance	1989	98
Intermittent clobazam for catamenial epilepsy: tolerance avoided. M. Feely, John S. Gibson Journal of Neurology Neurosurgery & Psychiatry Neurobiology Of DiseasePsychotropic MedicationClobazam TherapyPharmacologySuccessive Menstrual Cycles	1984	95
Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control. N. Callaghan, Michael O’Callaghan, B. Duggan, Journal of Neurology Neurosurgery & Psychiatry Single DrugMedicinePsychotropic MedicationSide EffectsNeuropharmacology	1978	72
Differences between the tolerance characteristics of two anticonvulsant benzodiazepines J P Gent, M. Feely, Jeremy R.M. Haigh Life Sciences Tolerance CharacteristicsMedicinePsychopharmacologyNeuropharmacologyPharmacotherapy	1985	66
THE USE OF A PHARMACOLOGICAL INDICATOR TO INVESTIGATE COMPLIANCE IN PATIENTS WITH A POOR RESPONSE TO ANTIRHEUMATIC THERAPY T Pullar, S Peaker, M F Martin, Lara D. Veeken Rheumatoid DisorderRheumatologyMedicinePain MedicinePatient Safety	1988	63
Doctors' unawareness of the drugs their patients are taking: a major cause of overprescribing? D. J. Price, Jonathan Cooke, Stephan Singleton, BMJ	1986	61
Burns because of epilepsy K.K. Hampton, R C Peatfield, T Pullar, BMJ EpidemiologyMalades Atteints D'epilepsieNeurophysiologyNeurological DisorderBurn Management	1988	55
N‐desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy? JR Haigh, T Pullar, J P Gent, British Journal of Clinical Pharmacology Molecular NeuroscienceRefractory EpilepsyMedicinePsychotropic MedicationPsychopharmacology	1987	48

Page 1